Trial · NCT02723955
Adverse events21,629
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 21,629Pages stop at row 10,000
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Part 1A: Feladilimab (Fela) 0.001 Milligram/Kilogram (mg/kg) | 0 | 1 | 0 |
| other | Anaemia | Blood and lymphatic system disorders | Part 1A: Fela 0.003 mg/kg | 0 | 1 | 0 |
| other | Anaemia | Blood and lymphatic system disorders | Part 1A: Fela 0.010 mg/kg | 0 | 2 | 0 |
| other | Anaemia | Blood and lymphatic system disorders | Part 1A: Fela 0.030 mg/kg | 1 | 7 | 1 |
| other | Anaemia | Blood and lymphatic system disorders | Part 1A: Fela 0.100 mg/kg | 7 | 24 | 7 |
| other | Anaemia | Blood and lymphatic system disorders | Part 1A: Fela 0.300 mg/kg | 5 | 25 | 5 |
| other | Anaemia | Blood and lymphatic system disorders | Part 1A: Fela 1.000 mg/kg | 4 | 15 | 5 |
| other | Anaemia | Blood and lymphatic system disorders | Part 1A: Fela 3.000 mg/kg | 2 | 27 | 2 |
| other | Anaemia | Blood and lymphatic system disorders | Part 1A: Fela 10.000 mg/kg | 2 | 7 | 2 |
| other | Anaemia | Blood and lymphatic system disorders | Part 1B: Fela 0.300 mg/kg | 7 | 39 | 7 |
| other | Anaemia | Blood and lymphatic system disorders | Part 1B: Fela 1.000 mg/kg | 29 | 115 | 32 |
| other | Anaemia | Blood and lymphatic system disorders | Part 1B: Fela 24 mg | 6 | 59 | 7 |
| other | Anaemia | Blood and lymphatic system disorders | Part 2A: Fela 0.010 mg/kg + Pembrolizumab (Pembro) 200 mg | 0 | 5 | 0 |
| other | Anaemia | Blood and lymphatic system disorders | Part 2A: Fela 0.030 mg/kg + Pembro 200 mg | 1 | 5 | 1 |
| other | Anaemia | Blood and lymphatic system disorders | Part 2A: Fela 0.100 mg/kg + Pembro 200 mg | 0 | 5 | 0 |
| other | Anaemia | Blood and lymphatic system disorders | Part 2A: Fela 0.300 mg/kg + Pembro 200 mg | 1 | 8 | 1 |
| other | Anaemia | Blood and lymphatic system disorders | Part 2A: Fela 1.000 mg/kg + Pembro 200 mg | 3 | 11 | 4 |
| other | Anaemia | Blood and lymphatic system disorders | Part 2A: Fela 3.000 mg/kg + Pembro 200 mg | 3 | 11 | 3 |
| other | Anaemia | Blood and lymphatic system disorders | Part 2A: Fela 8 mg + GSK3174998 8 mg | 0 | 1 | 0 |
| other | Anaemia | Blood and lymphatic system disorders | Part 2A: Fela 8 mg + GSK3174998 24 mg | 0 | 4 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02723955/events